as science and technology converge, ground-breaking developments in medicine continue to emerge. cramer is focusing in on one biotech that could be on the verge of a major move. >>> remember that therapeutics, the tiny biotech stock that like tripled on wednesday. incredible move. it seems like the easy money has already been made, but other biotechs have the same type of thing going and have potential to give you similar gains. i doubt that any others go up 199% on the day. what could be the next cerepa? if you speculate on high-risk, high-reward, the sweet spot is those who develop orphan drugs, drugs that help people who suffer from extremely rare disease with there is no cure, but it's a small case. serepta has developed a drug that helps people who have muscular dystrophy. they will be able to charge hundreds of thousands of dollars a year for a course of treatment if the fda gives its seal of approval. you want to put on your daddy war bucks hat. get your hands on as many orphans as possible. the more the, the merrier. i want to circle back to another orphan drug. rt x. ver